Two-year data show that adding VNS to standard care can produce lasting symptom, function, and quality-of-life benefits in one of the most difficult-to-treat depression populations.
Study: Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report. Image credit: BigBlueStudio/Shutterstock.com
In a recent study published in the International Journal of Neuropsychopharmacology, researchers characterized function, depressive symptoms, and quality of life (QoL) over two years of vagus nerve stimulation (VNS) in individuals with severe, chronic treatment-resistant depression (TRD).
High treatment resistance limits long-term depression outcomes
Most people with major depressive disorder improve with one to three attempts of antidepressant…